Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on September 7, 2004

Circulation. 2004
Published online before print September 7, 2004, doi: 10.1161/01.CIR.0000142085.39015.31
A more recent version of this article appeared on September 21, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/12/1678    most recent
01.CIR.0000142085.39015.31v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chi, H.
Right arrow Articles by Amar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chi, H.
Right arrow Articles by Amar, S.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Animal models of human disease
Right arrow Risk Factors
Right arrow Genetically altered mice
Right arrow Growth factors/cytokines
Right arrow Mechanism of atherosclerosis/growth factors

Submitted on December 29, 2003
Revised on May 4, 2004
Accepted on May 6, 2004

Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and/or a High-Fat Diet in a Murine Apolipoprotein E Heterozygote Model. Pharmacotherapeutic Implications

Hunghui Chi DDS, Emmanuel Messas MD, MSc, Robert A. Levine MD, Dana T. Graves DDS, DSc, and Salomon Amar DDS, PhD*

From the Department of Periodontology and Oral Biology (H.C., D.T.G., S.A.), School of Dental Medicine, Department of Pathology, Boston University, and Massachusetts General Hospital (E.M., R.A.L.), Boston, Mass.

* To whom correspondence should be addressed. E-mail: samar{at}bu.edu.

Background--Current data demonstrate that progressive atherosclerosis is associated with activation of the inflammatory process, as evidenced by systemic elevations of molecules such as tumor necrosis factor, interleukin (IL)-6, and IL-1. It has been postulated that inflammatory events within an atherogenic lesion are induced by oxidized LDL. Recent evidence suggests that infectious agents, including those that cause periodontal disease, may also play an important role. Studies presented here tested the hypothesis that IL-1 receptor (IL-1R1) signaling plays a crucial role in bacteria- and/or high-fat diet (HFD)-enhanced atherogenesis.

Methods and Results--Ten-week-old ApoE+/- mice lacking either 1 IL-1R1 allele (ApoE+/-/IL-1R1+/-) or 2 IL-1R1 alleles (ApoE+/-/IL-1R1-/-) fed either an HFD or regular chow were inoculated intravenously with live Porphyromonas gingivalis (P gingivalis) (107 CFU), an important periodontal pathogen, or vehicle once per week for 14 or 24 consecutive weeks. Histomorphometry of plaque cross-sectional area in the proximal aortas, en face measurement of plaque area over the aortic trees, and ELISA for systemic proinflammatory mediators were performed. Atherosclerotic lesions of proximal aortas and aortic tree were substantially reduced in ApoE+/-/IL-1R1-/- mice than in ApoE+/-/IL-1R1+/- mice challenged with P gingivalis. At 24 weeks after P gingivalis inoculation, proximal aortic lesion size quantified by histomorphometry was 5-fold-reduced in chow-fed ApoE+/-/IL-1R1-/- mice than in ApoE+/-/IL-1R1+/- mice (P<0.05). In the HFD group, ApoE+/-/IL-1R1-/- mice exhibited marked attenuation of the progression of atherosclerotic lesions (78% to 97%), with and without P gingivalis inoculation (P<0.05)

Conclusion--Ablation of IL-1R1 under P gingivalis challenge and/or an HFD reduced the progression of atherosclerotic plaques. These results indicate that IL-1 plays a crucial role in bacteria- and/or HFD-enhanced atherogenesis.


Key words: atherosclerosis • infection • interleukins • cardiovascular diseases • Porphyromonas gingivalis




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Amar, S.-c. Wu, and M. Madan
Is Porphyromonas gingivalis Cell Invasion Required for Atherogenesis? Pharmacotherapeutic Implications
J. Immunol., February 1, 2009; 182(3): 1584 - 1592.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Kleemann, S. Zadelaar, and T. Kooistra
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Cardiovasc Res, August 1, 2008; 79(3): 360 - 376.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Koizumi, T. Kurita-Ochiai, S. Oguchi, and M. Yamamoto
Nasal Immunization with Porphyromonas gingivalis Outer Membrane Protein Decreases P. gingivalis-Induced Atherosclerosis and Inflammation in Spontaneously Hyperlipidemic Mice
Infect. Immun., July 1, 2008; 76(7): 2958 - 2965.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. M. Holdt, J. Thiery, J. L. Breslow, and D. Teupser
Increased ADAM17 mRNA Expression and Activity Is Associated With Atherosclerosis Resistance in LDL-Receptor Deficient Mice
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1097 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
H. Loppnow, K. Werdan, and M. Buerke
Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Innate Immunity, April 1, 2008; 14(2): 63 - 87.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Amar, Q. Zhou, Y. Shaik-Dasthagirisaheb, and S. Leeman
From the Cover: Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge
PNAS, December 18, 2007; 104(51): 20466 - 20471.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Wolfrum, D. Teupser, M. Tan, K. Y. Chen, and J. L. Breslow
The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-{kappa}B target genes
PNAS, November 20, 2007; 104(47): 18601 - 18606.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kawamura, D. Baitsch, R. Telgmann, R. Feuerborn, G. Weissen-Plenz, C. Hagedorn, K. Saku, S.-M. Brand-Herrmann, A. von Eckardstein, G. Assmann, et al.
Apolipoprotein E Interrupts Interleukin-1{beta} Signaling in Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1610 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Schultz, V. Murthy, J. B. Tatro, and D. Beasley
Endogenous interleukin-1{alpha} promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2927 - H2934.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. von Hundelshausen and C. Weber
Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease
Circ. Res., January 5, 2007; 100(1): 27 - 40.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Brodala, E. P. Merricks, D. A. Bellinger, D. Damrongsri, S. Offenbacher, J. Beck, P. Madianos, D. Sotres, Y.-L. Chang, G. Koch, et al.
Porphyromonas gingivalis Bacteremia Induces Coronary and Aortic Atherosclerosis in Normocholesterolemic and Hypercholesterolemic Pigs
Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1446 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. P.J. de Winther, E. Kanters, G. Kraal, and M. H. Hofker
Nuclear Factor {kappa}B Signaling in Atherogenesis
Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 904 - 914.
[Abstract] [Full Text] [PDF]